Northern Lincolnshire and Goole NHS Foundation Trust - Nuclear Medicine
When this document is not viewed in the Nuclear Medicine Wiki, the reader is responsible for checking that it is the most current version. This can be checked at nlag.heynm.org.uk
| SOP Code | Title | Review Date |
|---|---|---|
| REF002 | Radionuclide Ventriculography | 2028-01-07 |
| Authorised By | Authorising Role | Authorisation Signature (only on master paper copy) | Date Authorised |
|---|---|---|---|
| Dr M Balerdi | ARSAC Licence Holder | 2025-01-07 |
See REF000 - Referring to Nuclear Medicine (NLAG) for details on how to refer.
Radionuclide ventriculography (sometime referred to as a MUGA scan) is a reproducible technique for assessing left ventricular function and left ventricular ejection fraction. It is performed by in-vivo labelling of red cells with a radioactive tracer followed by acquiring ECG gated images on a gamma camera.
| ARSAC Licence Holders |
|---|
| Dr Matt Balerdi |
| Prof Ged Avery |
| Dr Najeeb Ahmed |
| Nuclide | Pharmaceutical Form | Local DRL (MBq) |
|---|---|---|
| Tc99m | Pertechnetate (after inactive stannous agent/PYP) | 400 |
| Typical Radiation Dose (mSv) | 2.8mSv for 400MBq |
|---|
| Assessment of global left ventricular function[1][2] |
| Assessment of regional left ventricular function/wall motion abnormalities[2] |
| Assessment of diastolic function[2] |
| Serial measurement of left ventricular ejection fraction to assess left ventricular function following administration of chemotherapeutic or other cardiotoxic agents (e.g.Herceptin) [1][2] |
| Suspected heart failure (e.g. selection of patients for ACE inhibitor) [1] |
| Assessment of ventricular function in patients with valvular heart disease [1] |
| Assessment of left ventricular function prior to major surgery |
| Assessment of left ventricular function prior to cardiac transplantation |
| Assessment of left-to-right cardiac shunts (via first pass imaging) [2] |
| Assessment of right ventricular function (via first pass imaging) [2] |